Bloomberg
@business
The first word in business news | Watch Live: | Newsletters: | Podcasts:
Joined April 2009
107 Following 10.4M Followers
A Novartis drug billed as a potential blockbuster failed to reduce the risk of heart attacks and strokes in a final-stage trial, marking a major setback for a new approach to prevent cardiovascular disease
Show more
